Cardioselective example sentences

"Cardioselective" Example Sentences

1. Cardioselective beta-blockers are often preferred for treating hypertension in patients with asthma.
2. The study evaluated the efficacy of a new cardioselective drug on heart rate variability.
3. He was prescribed a cardioselective beta-blocker to manage his angina.
4. Understanding the cardioselective properties of beta-blockers is crucial for appropriate prescribing.
5. This medication is cardioselective, minimizing side effects on the lungs.
6. Are there any cardioselective alternatives to this medication?
7. The cardioselective nature of the drug reduces the risk of bronchospasm.
8. Many doctors prefer cardioselective beta-blockers for their patients with COPD.
9. The research highlighted the importance of choosing a cardioselective approach in beta-blocker therapy.
10. Cardioselective beta-adrenergic receptor antagonists are commonly used.
11. Its cardioselective action makes it suitable for patients with certain respiratory conditions.
12. The benefits of cardioselective agents outweigh the risks in this case.
13. This new drug exhibits superior cardioselective properties.
14. We need to assess the cardioselective profile of this compound.
15. The pharmaceutical company is developing a new cardioselective drug for heart failure.
16. Clinical trials showed the drug to be highly cardioselective.
17. This drug's cardioselective effect is a significant advantage.
18. The physician carefully considered the patient's respiratory history before prescribing a cardioselective beta-blocker.
19. Further research is needed to fully understand the cardioselective mechanism of this drug.
20. The cardioselective effect is dose-dependent.
21. Is this medication truly cardioselective, or are there off-target effects?
22. The debate continues on the optimal use of cardioselective beta-blockers.
23. Several factors influence the cardioselective action of beta-blockers.
24. The cardioselective properties were confirmed by in vitro studies.
25. A cardioselective approach is recommended in this specific situation.
26. The study compared the efficacy of cardioselective and non-cardioselective beta-blockers.
27. With its cardioselective properties, this drug reduces the risk of peripheral vasoconstriction.
28. The lack of significant bronchoconstriction highlights its cardioselective nature.
29. Its cardioselective profile makes it ideal for patients at risk of respiratory complications.
30. The development of cardioselective medications has improved patient outcomes.
31. Pharmacologists are always seeking to improve the cardioselective properties of beta-blockers.
32. The literature supports the use of cardioselective agents in managing certain cardiac conditions.
33. Cardioselective beta-blockers remain a cornerstone of cardiovascular disease management.
34. This particular beta-blocker has a high degree of cardioselective activity.
35. The drug's cardioselective action is a key factor in its safety profile.
36. What are the advantages and disadvantages of using a cardioselective approach?
37. Monitoring for side effects is essential when using cardioselective medications.
38. The precise mechanism of its cardioselective action remains unclear.
39. The patient tolerated the cardioselective medication well.
40. The research team focused on enhancing the cardioselective activity of the molecule.
41. A cardioselective drug was chosen for its favorable side effect profile.
42. The results demonstrated a statistically significant difference between the cardioselective and non-cardioselective groups.
43. Improved cardioselective beta-blockers are constantly under development.
44. It's important to understand the limitations of cardioselective medications.
45. The long-term effects of cardioselective therapy require further investigation.
46. Recent studies have questioned the absolute cardioselective nature of some drugs.
47. Determining the degree of cardioselective action is critical for effective treatment.
48. This area of research seeks to clarify the cardioselective impact of the drug.
49. The clinical significance of cardioselective properties is still being debated.
50. Future drug development will likely focus on improving cardioselective specificity.